| Dr Yu Chiu, MD | |
|
4755 Ogletown Stanton Rd # 231, Newark, DE 19718-2200 | |
| (302) 623-3451 | |
| (302) 325-6678 |
| Full Name | Dr Yu Chiu |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 9 Years |
| Location | 4755 Ogletown Stanton Rd # 231, Newark, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306227640 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | 71007-21 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christiana Hospital | Newark, DE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Christiana Care Health Services Inc | 9739097569 | 1248 |
News Archive
Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's applications for six new presentations of therapeutic heparin in single- and multiple-dose vials.
New data presented at the American Association for Cancer Research's Seventh Annual International Frontiers in Cancer Prevention Research meeting outlines new data, which assesses breast cancer risk among women with a strong family history of breast cancer, but without a BRCA1 or BRCA2 mutation.
Sending discharge letters to patients as well as their GPs when they leave UK hospitals could make a substantial difference to patient outcomes, according to a new study by University of Warwick researchers.
To help cancer patients and their families better understand their treatment options before making a decision, the American Society for Therapeutic Radiology and Oncology has published seven patient information brochures that explain how radiation therapy is used to safely and effectively treat various cancers.
Genetic testing of tumor and blood fluid samples from people with and without one of the most aggressive forms of skin cancer has shown that two new blood tests can reliably detect previously unidentifiable forms of the disease.
› Verified 7 days ago
| Entity Name | Christiana Care Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770568107 PECOS PAC ID: 9739097569 Enrollment ID: O20031201000477 |
News Archive
Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's applications for six new presentations of therapeutic heparin in single- and multiple-dose vials.
New data presented at the American Association for Cancer Research's Seventh Annual International Frontiers in Cancer Prevention Research meeting outlines new data, which assesses breast cancer risk among women with a strong family history of breast cancer, but without a BRCA1 or BRCA2 mutation.
Sending discharge letters to patients as well as their GPs when they leave UK hospitals could make a substantial difference to patient outcomes, according to a new study by University of Warwick researchers.
To help cancer patients and their families better understand their treatment options before making a decision, the American Society for Therapeutic Radiology and Oncology has published seven patient information brochures that explain how radiation therapy is used to safely and effectively treat various cancers.
Genetic testing of tumor and blood fluid samples from people with and without one of the most aggressive forms of skin cancer has shown that two new blood tests can reliably detect previously unidentifiable forms of the disease.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yu Chiu, MD 4755 Ogletown Stanton Rd # 231, Newark, DE 19718-2200 Ph: (302) 623-3451 | Dr Yu Chiu, MD 4755 Ogletown Stanton Rd # 231, Newark, DE 19718-2200 Ph: (302) 623-3451 |
News Archive
Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's applications for six new presentations of therapeutic heparin in single- and multiple-dose vials.
New data presented at the American Association for Cancer Research's Seventh Annual International Frontiers in Cancer Prevention Research meeting outlines new data, which assesses breast cancer risk among women with a strong family history of breast cancer, but without a BRCA1 or BRCA2 mutation.
Sending discharge letters to patients as well as their GPs when they leave UK hospitals could make a substantial difference to patient outcomes, according to a new study by University of Warwick researchers.
To help cancer patients and their families better understand their treatment options before making a decision, the American Society for Therapeutic Radiology and Oncology has published seven patient information brochures that explain how radiation therapy is used to safely and effectively treat various cancers.
Genetic testing of tumor and blood fluid samples from people with and without one of the most aggressive forms of skin cancer has shown that two new blood tests can reliably detect previously unidentifiable forms of the disease.
› Verified 7 days ago